Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. / Laakso, M; Zilinskaite, J; Hansen, T; Boesgaard, T Welløv; Vänttinen, M; Stancáková, A; Jansson, P-A; Pellmé, F; Kuulasmaa, T; Hribal, M L; Sesti, G; Stefan, N; Fritsche, A; Häring, H; Pedersen, Oluf; Smith, U; EUGENE2 Consortium ; Holst, Jens Juul.

    In: Diabetologia, Vol. 51, No. 3, 2008, p. 502-11.

    Research output: Contribution to journalJournal article

  2. Published

    Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. / Koopmann, Matthew C; Nelson, David W; Murali, Sangita G; Liu, Xiaowen; Brownfield, Mark S; Holst, Jens Juul; Ney, Denise M.

    In: Journal of Parenteral and Enteral Nutrition, Vol. 32, No. 3, 30.04.2008, p. 254-65.

    Research output: Contribution to journalJournal article

  3. Published

    Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats. / Koopmann, M.C.; Nelson, D.W.; Murali, S.G.; Liu, X.W.; Brownfield, M.S.; Holst, Jens Juul; Ney, D.M.

    In: Journal of Parenteral and Enteral Nutrition, Vol. 32, No. 3, 2008, p. 254-265.

    Research output: Contribution to journalJournal article

  4. Published

    Replacing SUs with incretin-based therapies for type 2 diabetes mellitus : challenges and feasibility. / Knop, Filip K; Holst, Jens Juul; Vilsbøll, Tina.

    In: I Drugs: the Investigational Drugs Journal, Vol. 11, No. 7, 07.2008, p. 497-501.

    Research output: Contribution to journalJournal article

  5. Published

    Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: Challenges and feasibility. / Knop, F.K.; Holst, Jens Juul; Vilsbøll, Tina.

    In: IDrugs. The Investigational Drugs Journal, Vol. 11, No. 7, 2008, p. 497-501.

    Research output: Contribution to journalJournal article

  6. Published

    Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis. / Kalaitzakis, Evangelos; Sadik, Riadh; Holst, Jens Juul; Ohman, Lena; Björnsson, Einar.

    In: Clinical Gastroenterology and Hepatology, Vol. 7, No. 3, 2008, p. 346-52.

    Research output: Contribution to journalJournal article

  7. Published

    The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat. / Kaji, Tatsuru; Tanaka, Hiroaki; Holst, Jens Juul; Redstone, Heather; Wallace, Laurie; de Heuval, Elaine; Sigalet, David L.

    In: European Journal of Pharmacology, Vol. 596, No. 1-3, 31.10.2008, p. 138-45.

    Research output: Contribution to journalJournal article

  8. Published

    Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection. / Kaji, Tatsuru; Tanaka, Hiroaki; Redstone, Heather; Wallace, Laurie E; Holst, Jens J; Sigalet, David L.

    In: Journal of Surgical Research, Vol. 152, No. 2, 2008, p. 271-80.

    Research output: Contribution to journalJournal article

  9. Published

    The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat. / Kaji, T.; Tanaka, H.; Holst, Jens Juul; Redstone, H.; Wallace, L.; Heuval, E. de; Sigalet, D.L.

    In: European Journal of Pharmacology, Vol. 596, No. 1-3, 2008, p. 138-145.

    Research output: Contribution to journalJournal article

  10. Published

    Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes. / Højberg, P V; Zander, M; Vilsbøll, T; Knop, F K; Krarup, T; Vølund, A; Holst, Jens Juul; Madsbad, S.

    In: Diabetologia, Vol. 51, No. 4, 04.2008, p. 632-40.

    Research output: Contribution to journalJournal article

ID: 4207